D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 65 Citations 14,029 328 World Ranking 1925 National Ranking 69

Overview

What is she best known for?

The fields of study she is best known for:

  • Cancer
  • Immune system
  • Gene

Immunology, Dendritic cell, Immune system, Immunotherapy and Cancer are her primary areas of study. The study incorporates disciplines such as Melanoma and Cell biology in addition to Immunology. Her Dendritic cell research incorporates themes from Myeloid, Cancer research, Progenitor cell, CD14 and Vaccination.

Her research integrates issues of Stage, Cervical intraepithelial neoplasia and Lymphoma in her study of Immune system. Her Immunotherapy research is multidisciplinary, incorporating elements of Cytotoxic T cell, Regulation of gene expression and Transporter. Her work on Cervical cancer and Cancer immunotherapy as part of general Cancer study is frequently linked to Context, therefore connecting diverse disciplines of science.

Her most cited work include:

  • Functional delivery of viral miRNAs via exosomes (1153 citations)
  • Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. (505 citations)
  • Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial (290 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of study are Immunology, Cancer research, Dendritic cell, Immune system and T cell. As a member of one scientific family, she mostly works in the field of Immunology, focusing on Cytotoxic T cell and, on occasion, Molecular biology. Her work carried out in the field of Cancer research brings together such families of science as Cervical cancer, Cell, Ex vivo and CD40.

Tanja D. de Gruijl has researched Dendritic cell in several fields, including Cellular differentiation, Myeloid, Myeloid leukemia, Melanoma and Cell biology. Her Immune system study combines topics in areas such as Bone marrow and Vaccination. Tanja D. de Gruijl has included themes like Priming, Cytokine and FOXP3 in her T cell study.

She most often published in these fields:

  • Immunology (53.12%)
  • Cancer research (31.25%)
  • Dendritic cell (28.12%)

What were the highlights of her more recent work (between 2018-2021)?

  • Cancer research (31.25%)
  • Immune system (26.74%)
  • Immunotherapy (25.00%)

In recent papers she was focusing on the following fields of study:

Tanja D. de Gruijl spends much of her time researching Cancer research, Immune system, Immunotherapy, T cell and Tumor microenvironment. Many of her research projects under Cancer research are closely connected to CpG site with CpG site, tying the diverse disciplines of science together. Her Immune system study is concerned with the field of Immunology as a whole.

Her Immunotherapy research includes themes of Ex vivo, Oncology and Oncolytic virus. Her T cell study combines topics from a wide range of disciplines, such as Dendritic cell, CD8, Lymph node, Degranulation and Chronic lymphocytic leukemia. Her Dendritic cell research is multidisciplinary, incorporating perspectives in CTLA-4 and Cell biology.

Between 2018 and 2021, her most popular works were:

  • Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19. (43 citations)
  • High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy (32 citations)
  • Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study. (17 citations)

In her most recent research, the most cited papers focused on:

  • Cancer
  • Immune system
  • Gene

Her scientific interests lie mostly in Cancer research, Antigen, Immunotherapy, Internal medicine and Oncology. Her work deals with themes such as Cervical cancer, Immune modulation, Immune system and Vaccination, which intersect with Cancer research. Tanja D. de Gruijl has included themes like Breast cancer, Primary tumor, Melanoma and Lymph in her Immune system study.

Her Antigen study integrates concerns from other disciplines, such as T cell, Antigen-presenting cell and Cell biology. Cell biology is closely attributed to CD8 in her study. Her Immunotherapy study incorporates themes from Tumor microenvironment, Ovarian cancer, Radiation therapy and Respiratory virus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Functional delivery of viral miRNAs via exosomes

D. Michiel Pegtel;Katherine Cosmopoulos;David A. Thorley-Lawson;Monique A. J. van Eijndhoven.
Proceedings of the National Academy of Sciences of the United States of America (2010)

1680 Citations

Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.

Lot de Witte;Alexey Nabatov;Marjorie Pion;Donna Fluitsma.
Nature Medicine (2007)

746 Citations

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Alfons J M van den Eertwegh;Jurjen Versluis;H Pieter van den Berg;Saskia J A M Santegoets.
Lancet Oncology (2012)

475 Citations

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

A. N. Niemeijer;D. Leung;M. C. Huisman;I. Bahce.
Nature Communications (2018)

261 Citations

Prostanoids Play a Major Role in the Primary Tumor-Induced Inhibition of Dendritic Cell Differentiation

Claudia C. Sombroek;Anita G. M. Stam;Allan J. Masterson;Sinéad M. Lougheed.
Journal of Immunology (2002)

253 Citations

CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.

Rodney A. Rosalia;Luis J. Cruz;Suzanne van Duikeren;Angelino T. Tromp.
Biomaterials (2015)

249 Citations

Maturation of Dendritic Cells Accompanies High-Efficiency Gene Transfer by a CD40-Targeted Adenoviral Vector

Bryan W. Tillman;Tanja D. De Gruijl;Sylvia A. Luykx-de Bakker;Rik J. Scheper.
Journal of Immunology (1999)

236 Citations

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

Tanja D. de Gruijl;Alfons J. M. van den Eertwegh;Herbert M. Pinedo;Rik J. Scheper.
Cancer Immunology, Immunotherapy (2008)

218 Citations

Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.

A. Marijne Heeren;Simone Punt;Maaike C. G. Bleeker;Katja N. Gaarenstroom.
Modern Pathology (2016)

205 Citations

MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors

Allan J Masterson;Claudia C Sombroek;Tanja D De Gruijl;Yvo M F Graus.
Blood (2002)

199 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Tanja D. de Gruijl

Susan Gibbs

Susan Gibbs

Vrije Universiteit Amsterdam

Publications: 37

David T. Curiel

David T. Curiel

Washington University in St. Louis

Publications: 36

Sjoerd H. van der Burg

Sjoerd H. van der Burg

Leiden University Medical Center

Publications: 35

Yvette van Kooyk

Yvette van Kooyk

Vrije Universiteit Amsterdam

Publications: 34

Cornelis J. M. Melief

Cornelis J. M. Melief

ISA Pharmaceuticals (Netherlands)

Publications: 32

Takahiro Ochiya

Takahiro Ochiya

Tokyo Medical University

Publications: 29

Anthony L. Cunningham

Anthony L. Cunningham

University of Sydney

Publications: 28

Marij J. P. Welters

Marij J. P. Welters

Leiden University Medical Center

Publications: 26

Jérôme Galon

Jérôme Galon

Université Paris Cité

Publications: 25

Nobuyoshi Kosaka

Nobuyoshi Kosaka

Tokyo Medical University

Publications: 24

Bernard A. Fox

Bernard A. Fox

Earle A. Chiles Research Institute

Publications: 24

Gerrit Jansen

Gerrit Jansen

Amsterdam UMC

Publications: 23

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 22

James L. Gulley

James L. Gulley

National Institutes of Health

Publications: 22

Antonin de Fougerolles

Antonin de Fougerolles

Alnylam Pharmaceuticals (United States)

Publications: 22

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 21

Trending Scientists

Doug A. Bowman

Doug A. Bowman

Virginia Tech

Sunil Prabhakar

Sunil Prabhakar

Purdue University West Lafayette

Vincent J. Zimmer

Vincent J. Zimmer

Intel (United States)

Irfan Anjum Badruddin

Irfan Anjum Badruddin

King Khalid University

Chin-Hsiung Loh

Chin-Hsiung Loh

National Taiwan University

Antonella Gervasini

Antonella Gervasini

University of Milan

Mohd Ali Hashim

Mohd Ali Hashim

University of Malaya

Lukas Novotny

Lukas Novotny

ETH Zurich

Miguel Vences

Miguel Vences

Technische Universität Braunschweig

Alexandre Benmerah

Alexandre Benmerah

Institut Imagine

Elizabeth M. McNally

Elizabeth M. McNally

Northwestern University

Takeshi Urano

Takeshi Urano

Shimane University

Jostein Bakke

Jostein Bakke

University of Bergen

Kathrin Fenner

Kathrin Fenner

Swiss Federal Institute of Aquatic Science and Technology

Jonathan A. McCullers

Jonathan A. McCullers

University of Tennessee Health Science Center

Rebecca Dresser

Rebecca Dresser

Washington University in St. Louis

Something went wrong. Please try again later.